Brief: Femasys Announces Notice Of Allowance For New U.S. Patent Application Covering Use Of FemBloc For Female Permanent Birth Control
27/07/2023 15:11
July 27 (Reuters) - Femasys Inc FEMY.O :
* FEMASYS ANNOUNCES NOTICE OF ALLOWANCE FOR NEW U.S. PATENT
APPLICATION COVERING USE OF FEMBLOC FOR FEMALE PERMANENT BIRTH
CONTROL
* FEMASYS INC - EXPECTS RESULTING PATENT, WHEN ISSUED, WILL
HAVE
AN ANTICIPATED EXPIRATION IN 2039 AT EARLIEST
Source text for Eikon: ID:nGNX8qTff6
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview